“The Chinese government is expected to funnel as much as $132 million annually into [stem cell] research over the next five years.” -UK Stem Cell Initiative
European Stem Cell and Regenerative Medicine Congress
Date:May 13-15, 2008
Royal Horseguards Hotel, London, UK
The business behind stem cells
• Moving the industry from bench to bedside: emerging into a competitive market place • Case study updates: commercial expectations, clinical trial progress and best practice • Understand regulatory, IP and reimbursement guidelines • Drug discovery day: undertake groundbreaking stem cell research for immediate application • Enhanced networking: meet your peers, share knowledge and do business!
Keynote representation
Dr Alan Trounson President California Institute of Regenerative Medicine
Bernard Siegel Executive Director Genetics Policy Institute
Dr Alan Russell Director McGowan Institute for Regenerative Medicine
Additional key speakers include
Dr Thomas Okarma Chief Executive Officer Geron
Dr Michael West Chief Executive Officer Biotime
Dr John McNeish Senior Director Pfizer Global R&D
Dr Michael Hunt Chief Executive Officer ReNeuron
Dr Ajan Reginald Global Head of Emerging Group Research Roche
• Pharmaceutical manufacturers • Biotechs • Contract research organisations • Contract manufacturing organisations • Equipment and technology providers • Government research institutes • Academia and clinicians • Regional development agencies • Venture capitalists & law firms • Research foundations • Stem cell research centres
What’s in it for you? Benefits of attending
• Latest research in the field of stem cell therapeutics through exposition of multiphase clinical trials • Funding opportunities for emerging therapies • New and established stem cell companies offer their insights • The most recent consortia approach to stem cell business development • Business models for commercialising your therapy • Developments within the IP regulatory and reimbursement landscape • Contract and clinical manufacturing advancements • The development of an international industry association for regenerative medicine
